In the context of mediated society, digital technology has almost become an important puzzle piece in the underlying logic of the entire society. In this era, it is difficult for us to talk about industrial upgrading without digitization.

Although the medical industry is more rigorous and the level of digitization is relatively lagging compared to other industries, a series of new policies such as volume procurement, DRG, DIP, and medical service price reform, as well as industrial structure adjustment and the value game of all parties, digitization Medical care has become an indispensable part of every medical industry participant like mobile phones and Internet people.

Understanding the internal logic of medical digital transformation and its ultimate purpose is particularly critical to solving the current "stuck neck" problem of medical digital transformation and finding the direction of industrial development boosted by digital technology.

During the three-day conference, representatives from various circles of "government, industry, academia, research and medical investment" from all over the country will focus on digital medical care, AI and computing-driven new drug research and development, primary medical care, payment innovation, genetic testing, traditional Chinese medicine health care, and smart old-age care. Seven Topics such as market environment, investment hotspots, and industrial changes in major segments shared their insights on the industry at the conference, providing ideas for the digital transformation of medical care from various dimensions.

Driven by policy, economy, and technology as the core forces, the development models and industrial elements in the big health ecosystem are now more diverse than in the past. However, as the industry gradually matures, the “distributed innovation” form that the industry upgraded and reconstructed the medical industry through single-point innovation and breakthroughs one by one in the past is shifting to “integrated innovation” based on integration and coordinated development.

At the opening ceremony, Qi Xuchun, vice-chairman of the 12th National Committee of the Chinese People's Political Consultative Conference and former executive vice-chairman of the Central Committee of the Republic of China, pointed out: "With the continuous deepening of the new medical reform, the continuous advancement of the Healthy China 2030 plan, and the country's efforts to double the health industry Advocating circular development, China's health industry is entering a new situation of transition, acceleration, and the coexistence of challenges and opportunities. The transformation of China's health industry requires changing the traditional way of thinking and competition, promoting win-win through symbiosis, and Integration promotes development.”

Taking the cooperation between innovative pharmaceutical companies and disease screening companies as an example, it is believed that through this form of cooperation, not only companies can benefit from it, but also more potential drug patients. Patients can also conduct continuous diagnosis and treatment and self-management of diseases outside the hospital through this form of industrial cooperation.